ロムルチド
English Journal
- A synthetic NOD2 agonist, muramyl dipeptide (MDP)-Lys (L18) and IFN-β synergistically induce dendritic cell maturation with augmented IL-12 production and suppress melanoma growth.
- Fujimura T1, Yamasaki K, Hidaka T, Ito Y, Aiba S.
- Journal of dermatological science.J Dermatol Sci.2011 May;62(2):107-15. doi: 10.1016/j.jdermsci.2011.02.002. Epub 2011 Feb 22.
- BACKGROUND: A synthetic NOD2 agonist, muramyl dipeptide (MDP)-Lys (L18), mimics the bacterial peptidoglycan moiety and acts as a powerful adjuvant that induces cell-mediated immunity.OBJECTIVE: To investigate the induction of antitumor immune response for malignant melanoma by IFN-β in combination
- PMID 21411292
- Analgesic effects of chemically synthesized NOD1 and NOD2 agonists in mice.
- Sato T1, Shikama Y, Shimauchi H, Endo Y, Takada H.
- Innate immunity.Innate Immun.2011 Feb;17(1):54-9. doi: 10.1177/1753425909351904. Epub 2010 Jan 18.
- Intracellular nucleotide-binding oligomerization domain (NOD)-like receptors, NOD1 and NOD2, recognize the diaminopimelic acid (DAP)-containing peptide moiety and muramyldipeptide (MDP) moiety of bacterial peptidoglycan, respectively. Muramyldipeptide has been reported to exert analgesic activity to
- PMID 20083500
- Differential effects of GM-CSF and G-CSF on infiltration of dendritic cells during early left ventricular remodeling after myocardial infarction.
- Naito K1, Anzai T, Sugano Y, Maekawa Y, Kohno T, Yoshikawa T, Matsuno K, Ogawa S.
- Journal of immunology (Baltimore, Md. : 1950).J Immunol.2008 Oct 15;181(8):5691-701.
- Several lines of evidence suggest that the immune activation after myocardial infarction (MI) induces secondary myocardial injury. Although dendritic cells (DC) are potent regulators of immunity, their role in MI is still undetermined. We investigated the effect of DC modulation by CSF on left ventr
- PMID 18832728
Japanese Journal
- PP502 末梢血単球由来の樹状細胞成熟化におけるRomurtide(Nopia~<TM>)の有効性に関する検討
- 小林 稔弘,篠原 尚,奥沢 正昭,岩本 充彦,豊田 昌夫,谷川 允
- 日本外科学会雑誌 102(臨時増刊), 349, 2001-03-10
- NAID 110003943416
- わが国における結核免疫学の発展 : 結核菌菌体成分の免疫活性を中心に
- 東 市郎
- 結核 73(2), 65-70, 1998-02-15
- … We have synthesized several hundreds of MDP derivatives and selected, MDP-Lys (L18), romurtide, as the candidate of cytokine inducer for the clinical application. … Romurtide is applied in cancer patients for the recovery of the number and functions of monocytes, neutrophils and platelets. …
- NAID 10008113328
- Romurtide, a synthetic muramyl dipeptide derivative, promotes megakaryocytopoiesis through stimulation of cytokine production in nonhuman primates with myelosuppression.
- Kenji Namba,Eiko Yamamura,Hironobu Nitanai,Tsuyoshi Otani,Ichiro Azuma.
- Collected papers from the Institute of Immunological Science Hokkaido University 20, 183-191, 1997
- NAID 110000001113
Related Links
- Romurtide is a medicine available in a number of countries worldwide. A list of US medications equivalent to Romurtide is available on the Drugs.com website. ... Drugs.com provides accurate and independent information on more ...
- Almurtide, also known as romurtide, is a synthetic muramyl dipeptide (MDP) H8analo... 524164 Almurtide Almurtide is a bio-active chemical. Detailed information has not been published. (... +1-919-636-5577 +1-919 -980 sales@ ...
Related Pictures